TFF PHARMACEUTICALS, INC. Forms 3, 4 and 5: Warrants

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows, 5 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

2023-08-17: Reporting owner Carlson Clint Duane | Double Black Diamond Offshore Ltd | CARLSON CAPITAL L P | Asgard Investment Corp. II; Form 3; Security Warrants (right to buy); Transaction Holding.
2022-11-22: Reporting owner Fletcher Aaron G.L.; Form 4; Security Common Stock Purchase Warrants; Transaction P Open market or private purchase of non-derivative or derivative security.
2019-10-29: Reporting owner Fletcher Aaron G.L.; Form 4; Security Warrants; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
2019-10-24: Reporting owner Fletcher Aaron G.L.; Form 3; Security Warrant; Transaction Holding.

Purchase (P)All rows

Transaction date	Reporting owner	Form	Security	Transaction	Shares	Price	Filing
2023-08-17 holding as of filing	Carlson Clint Duane \| Double Black Diamond Offshore Ltd \| CARLSON CAPITAL L P \| Asgard Investment Corp. II 10% Owner \| 10% Owner \| 10% Owner \| 10% Owner	3	Warrants (right to buy) Derivative · Indirect · See footnotes	Holding		$1.29 exercise price	2023-08-17
2022-11-22	Fletcher Aaron G.L. Director	4	Common Stock Purchase Warrants Derivative · Direct	P Open market or private purchase of non-derivative or derivative security	+21,735 21,735 owned after	$1.29 exercise price	2022-11-23
2019-10-29	Fletcher Aaron G.L. Director	4	Warrants Derivative · Indirect · (m)	A Grant, award or other acquisition pursuant to Rule 16b-3(d)	+43,794 179,693 owned after	$5.00 exercise price	2019-10-29
2019-10-24 holding as of filing	Fletcher Aaron G.L. Director	3	Warrant Derivative · Indirect · (m)	Holding		$2.50 exercise price	2019-10-24
2019-10-24 holding as of filing	Fletcher Aaron G.L. Director	3	Warrant Derivative · Indirect · (m)	Holding		$2.50 exercise price	2019-10-24